From Verify.Wiki
Jump to: navigation, search
QuickUpload1048 20170715131809.png
NeuroScios GmbH
Industry Research
Founded 2013
Number of employees 11-50

About Us

With 30 years of experience in CNS drug development we may offer you the fastest track from molecule to clinic. As a contract research organization we

-Support the development of new treatments for CNS diseases

-Alzheimer’s disease -Parkinson’s disease

-Orphan neurodegenerative disorders

-Cerebrovascular diseases

-Psychiatric diseases

-Accelerate the drug/ treatment development by our profound knowledge of the requirements




-Regulatory issues (IND/ CTA)

- Clinical trials

-Optimize the chance of success, by knowing

-the most suitable preclinical models

-the most experienced and reliable service providers

-the competitive environment

- Support our clients in the best way by

-Designing most efficient individualized development plan

-Providing an outstanding network of KOLs in different fields of CNS diseases

- Fastest reaction time

-Competitive pricing

- International experience for more than 30 years


  • Consulting
  • Clinical Neuroscience
  • CNS Clinical Research
  • Pharmacovigilance


Top 5 Recent Tweets

October 25, 2022DrSenthil5Manfred Windisch is CEO of NeuroScios—Neuroscience Optimized Solutions. NeuroScios specializes in consulting for dr…

Top 5 Recent News Headlines

Top 5 Lifetime Tweets

Top 5 Lifetime News Headlines

Verification history